Results 61 to 70 of about 16,329,415 (166)
Androgen Receptor Expression in Urothelial Bladder Cancer—A Systematic Review and Meta‐Analysis
ABSTRACT Background Bladder cancer is a globally prevalent malignancy with a marked male predominance. Over the past decade, the androgen receptor has been investigated as a potential contributor to bladder cancer pathophysiology. Androgen receptor expression is most commonly assessed via immunohistochemistry, but its association with pathological ...
Alex Buckby +3 more
wiley +1 more source
Surgical safety in radical cystectomy: the anesthetist's point of view-how to make a safe procedure safer. [PDF]
PURPOSE The aim of this review is to present an anesthesiological overview on surgical safety for radical cystectomy implementing the cornerstones of today's rapidly evolving field of perioperative medicine. METHODS This is a narrative review of
Furrer, Marc A. +3 more
core +2 more sources
This study characterizes heterogeneous mottled grayscale ultrasound echoes of ovarian immature teratoma as the “pebbled mosaic sign,” noting solid lesions correlate with advanced pathological grades. Preoperative identification of immature tissue informs operative stratification. Abstract Introduction Ovarian immature teratomas (ITs) are rare malignant
Tianyu Zhang +7 more
wiley +1 more source
Objective To further evaluate a genomic classifier (GC) in a cohort of patients undergoing radical cystectomy (RC), as long non‐coding RNA (lncRNA)‐based genomic profiling has suggested utility in identifying a distinct tumour subgroup corresponding to a favourable prognosis in patients with bladder cancer.
Joep J. de Jong +14 more
wiley +1 more source
Background: Radical cystectomy remains the standard treatment for invasive bladder cancer, yet it carries significant anesthetic risks. While robot-assisted surgery has gained popularity, data comparing its anesthetic implications to those of open ...
Sérgio Luiz do Logar Mattos +4 more
doaj +1 more source
Long‐term quality of life in patients with bladder cancer following radical cystectomy
Objectives To investigate changes in quality of life (QoL) up to 8 years after radical cystectomy (RC) and compare QoL after RC with a gender‐ and age‐matched Dutch normative population. Furthermore, we aimed to identify patient characteristics associated with QoL and QoL trajectories after RC.
Emine Akdemir +8 more
wiley +1 more source
The role of AIMP3, a putative tumour suppressor gene, as a predictive biomarker of response to chemo/radiotherapy in vitro and in patients with muscle-invasive bladder cancer. [PDF]
Bladder cancer is the second most common urological cancer after prostate cancer and is one of the leading causes of cancer mortality in most western countries.
Gurung, PMS
core
Robotic-assisted radical cystectomy
Objective To evaluate the emerging role of robotic-assisted radical cystectomy (RARC) in the management of bladder cancer. Methods Review of the published literature on robotic-assisted radical cystectomy, including data from our cystectomy series of 30 ...
Khan, Mohammad Shamim +4 more
core +1 more source
Radical cystectomy and regional lymph node dissection is the standard treatment for localized muscle-invasive and for high-risk non-muscle-invasive bladder cancer, and represents one of the main surgical urologic procedures. The open surgical approach
Barret E. +9 more
core +1 more source
Objective To examine the role of health‐related quality of life (HRQoL) assessments and patient‐reported outcome measures (PROMs) in the economic evaluation of urological interventions, highlighting methodological challenges, and identifying areas for future development.
Mohammed El Bahnasawi +4 more
wiley +1 more source

